ARRIVENT BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.30 USD | +0.18% |
|
+11.84% | +2.48% |
Chart calendar ArriVent BioPharma, Inc.
fa5090b5.Z0sjRs9SDL795NbfYDFvoiVFvb_y6ep8dM0RNLezqjg.ACpJd44cT4a1rqeGWH8jlH0HjMatmpMTRL1BBPPZ7msiD0Q8jTYh6pS17g~31b05ba4137dccea7ff7fecf42d7fa02
Upcoming events on ArriVent BioPharma, Inc.
Past events on ArriVent BioPharma, Inc.
| 2024-11-14 08:00 am | Q3 2024 Earnings Release |
| 2024-09-09 04:30 pm | Investor Meeting - Key Opinion Leader |
| 2024-09-09 11:58 am | Lung Cancer World Conference |
| 2024-08-14 04:01 pm | Q2 2024 Earnings Release |
| 2024-05-08 08:00 am | Q1 2024 Earnings Release |
| 2024-04-04 | American Association for Cancer Research Meeting |
| 2024-03-28 04:05 pm | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 -2,50 - | 0,00 | 0,00 | 4,85 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -74,6 -73,3 -1.82% | -96,9 | -126 | -172 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -74,6 -67,6 -10.39% | -98,3 | -120 | -140 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -69,3 -61,3 -13.18% | -84,7 | -107 | -115 |
|
Net income Million USD | Released Forecast Spread | -36,9 | -69,3 -61,3 -13.18% | -84,7 | -107 | -115 |
|
EPS USD | Released Forecast Spread | -1,90 | -32,4 -11,3 -186.39% | -2,74 | -3,23 | -3,59 |
| Announcement Date | 25/08/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -20,7 -19,2 -7.64% | -25,7 -21,6 -19.1% | -24,2 -26,8 9.73% | -26,3 | |||||
|
EBIT Million USD | Released Forecast Spread | -48,1 -24,3 -97.92% | -20,7 -29,2 29.18% | -25,7 -22,3 -15.04% | -24,2 -35,2 31.07% | -27,7 | -29,5 | -31,1 | -32,0 | -33,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,4 -19,4 10.35% | -21,9 -18,8 -16.28% | -20,6 -23,2 11.22% | -24,8 | -26,7 | -28,4 | -29,7 | -31,0 | |
|
Net income Million USD | Released Forecast Spread | -17,4 -19,4 10.35% | -21,9 -18,8 -16.28% | -20,6 -23,2 11.22% | -24,8 | -26,7 | -28,4 | -29,7 | -31,0 | |
|
EPS USD | Released Forecast Spread | -0,70 -0,94 25.23% | -0,65 -0,61 -7.28% | -0,61 -0,82 25.61% | -0,78 | -0,79 | -0,84 | -0,88 | -0,91 | |
| Announcement Date | 28/03/24 | 08/05/24 | 14/08/24 | 14/11/24 | - | - | - | - | - |
| 2025-01-28 | LONZA GROUP AG: Q4 2024 Earnings Release |
| 2025-02-05 06:30 am | BIO-TECHNE CORPORATION: Q2 2025 Earnings Release |
| 2025-02-05 04:05 pm | QIAGEN N.V.: Q4 2024 Earnings Release |
| 2025-02-05 | REPLIMUNE GROUP, INC.: Q3 2025 Earnings Release (Projected) |
| 2025-02-06 07:00 am | IQVIA HOLDINGS INC.: Q4 2024 Earnings Release |
| 2025-02-09 | MEDPACE HOLDINGS, INC.: Q4 2024 Earnings Release |
| 2025-02-10 | AZENTA, INC.: Q1 2025 Earnings Release (Projected) |
| 2025-02-11 | IMMUNOVANT, INC.: Q3 2025 Earnings Release (Projected) |
| 2025-02-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-02-12 04:01 pm | GALAPAGOS NV: Q4 2024 Earnings Release |
Past sector events for ArriVent BioPharma, Inc.
| 2025-01-23 04:30 am | SYNGENE INTERNATIONAL LIMITED: Q3 2025 Earnings Release |
| 2025-01-15 02:00 am | GENUS PLC: Q2 2025 Sales and Revenue Release - Trading Update |
| 2025-01-10 12:34 am | POLARIS GROUP: December 2024 Sales and Revenue Release |
| 2024-12-09 03:53 am | POLARIS GROUP: November 2024 Sales and Revenue Release |
| 2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
| 2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
| 2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
| 2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
| 2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
| 2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVBP Stock
- Calendar ArriVent BioPharma, Inc.